NEW YORK (GenomeWeb News) – GeneNews today reported that its net loss rose 74 percent year over year on higher R&D costs as the firm rolled its first commercial biomarker test.
 
The Toronto-based firm brought in revenues of $288,438 for the three-month period ended June 30, compared to no revenues in the second quarter of 2007. It said revenue from the most recent quarter came from a collaboration with an Asian biomedical consortium to identify and validate a set of biomarkers for prostate disease.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.